Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power 
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation 
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026 
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
CARLSBAD, Calif., March 15, 2016 -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the addition of Troy Woolley to its senior leadership team.
Mr. Woolley, who joined the company in September 2015 as Senior Director of Marketing, has been promoted to Vice President of Marketing, Spine Hardware. In addition to Mr. Woolley’s current responsibilities for Spine Hardware Marketing, he will also provide leadership and direction for the Global Marketing Services team supporting surgeon education, sales training, and branding. Mr. Woolley’s key priorities will include the timely launch and commercialization of new Spine Hardware products and developing cohesive corporate branding across both the Spine Hardware and Orthobiologics portfolios. Mr. Woolley brings over 20 years of product development and marketing experience and expertise to this new role.
Mr. Woolley will report directly to Keith Valentine, SeaSpine’s President and Chief Executive Officer.
“We are pleased to be strengthening our Senior Leadership Team through the new role for Troy, as his knowledge and experience are critically important to our goal of launching 8 to 10 new and next generation products and product line extensions each year,” said Keith Valentine, President and Chief Executive Officer of SeaSpine. “I look forward to Troy’s leadership and focus on our innovation pipeline and collaboration with the Spine Hardware product development team as we continue to grow and meet our strategic objectives.”
About SeaSpine
SeaSpine is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal fusion hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. SeaSpine’s orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine’s spinal fusion hardware portfolio consists of an extensive line of products to facilitate spinal fusion in minimally invasive surgery (MIS), complex spine, deformity and degenerative procedures. Expertise in both orthobiologic sciences and spinal fusion hardware product development allows SeaSpine to offer our surgeon customers a differentiated portfolio and a complete solution to meet their fusion requirements. SeaSpine currently markets its products in the United States and in over 30 countries worldwide.
Investor Relations Contact Lynn Pieper Lewis (415) 309-5999 [email protected]
